SENSEX
NIFTY
GOLD
USD/INR

Weather

image 32    C

Business News

The Economic Times

Business / The Economic Times

details

Why uniQure shares are sinking after AMT-130 update

uniQure shares plunged after four-year data for Huntingtons gene therapy AMT-130 showed weaker disease-progression slowing than earlier results. While 48-month TFC data remained encouraging, the cUHDRS effect was not statistically significant. Investors are now focused on FDA review and whether the therapys earlier benefits can demonstrate durability over time.

30 Sep 2026 11:10 am